- Home
- RPTX vs CXE Comparison
RPTX vs CXE Comparison
Compare RPTX & CXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- CXE
- Stock Information
- Founded
- RPTX 2016
- CXE 1989
- Country
- RPTX Canada
- CXE United States
- Employees
- RPTX N/A
- CXE N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- CXE Investment Managers
- Sector
- RPTX Health Care
- CXE Finance
- Exchange
- RPTX Nasdaq
- CXE Nasdaq
- Market Cap
- RPTX 141.1M
- CXE 122.3M
- IPO Year
- RPTX 2020
- CXE N/A
- Fundamental
- Price
- RPTX $1.32
- CXE $3.65
- Analyst Decision
- RPTX Strong Buy
- CXE
- Analyst Count
- RPTX 3
- CXE 0
- Target Price
- RPTX $7.00
- CXE N/A
- AVG Volume (30 Days)
- RPTX 709.5K
- CXE 62.9K
- Earning Date
- RPTX 11-07-2024
- CXE 01-01-0001
- Dividend Yield
- RPTX N/A
- CXE 4.36%
- EPS Growth
- RPTX N/A
- CXE N/A
- EPS
- RPTX N/A
- CXE 0.07
- Revenue
- RPTX $66,524,000.00
- CXE N/A
- Revenue This Year
- RPTX $13.22
- CXE N/A
- Revenue Next Year
- RPTX N/A
- CXE N/A
- P/E Ratio
- RPTX N/A
- CXE $51.00
- Revenue Growth
- RPTX 18.19
- CXE N/A
- 52 Week Low
- RPTX $1.23
- CXE $2.95
- 52 Week High
- RPTX $8.49
- CXE $3.67
- Technical
- Relative Strength Index (RSI)
- RPTX 30.27
- CXE 25.18
- Support Level
- RPTX $1.23
- CXE $3.63
- Resistance Level
- RPTX $4.07
- CXE $3.91
- Average True Range (ATR)
- RPTX 0.34
- CXE 0.05
- MACD
- RPTX -0.20
- CXE -0.02
- Stochastic Oscillator
- RPTX 3.34
- CXE 7.14
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.
About CXE MFS High Income Municipal Trust
Mfs High Income Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes.